BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35517503)

  • 1. EpCAM as a Novel Biomarker for Survivals in Prostate Cancer Patients.
    Liao Y; Wu M; Jia Y; Mou R; Li X
    Front Cell Dev Biol; 2022; 10():843604. PubMed ID: 35517503
    [No Abstract]   [Full Text] [Related]  

  • 2. Integrated analysis of lymphocyte infiltration-associated lncRNA for ovarian cancer via TCGA, GTEx and GEO datasets.
    Wu M; Shang X; Sun Y; Wu J; Liu G
    PeerJ; 2020; 8():e8961. PubMed ID: 32419983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Hypoxia-Related Gene Signature with Strong Predicting Ability in Non-Small-Cell Lung Cancer Identified by Comprehensive Profiling.
    Yang H; Wang Z; Gong L; Huang G; Chen D; Li X; Du F; Lin J; Yang X
    Int J Genomics; 2022; 2022():8594658. PubMed ID: 35634481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database.
    Xu M; Li Y; Li W; Zhao Q; Zhang Q; Le K; Huang Z; Yi P
    Front Med (Lausanne); 2020; 7():64. PubMed ID: 32195260
    [No Abstract]   [Full Text] [Related]  

  • 6. Exploring the role of differentially expressed metabolic genes and their mechanisms in bone metastatic prostate cancer.
    Zhang Q; Zhang P; Zhao Z; Wang J; Zhang H
    PeerJ; 2023; 11():e15013. PubMed ID: 37070095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Database Mining of Genes of Prognostic Value for the Prostate Adenocarcinoma Microenvironment Using the Cancer Gene Atlas.
    Zhao X; Hu D; Li J; Zhao G; Tang W; Cheng H
    Biomed Res Int; 2020; 2020():5019793. PubMed ID: 32509861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value and immunological role of SULF2 in adrenocortical carcinoma.
    Yan J; Xie X; Li Q; Liang P; Zhang J; Xu G
    Heliyon; 2023 Feb; 9(2):e13613. PubMed ID: 36852051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Prostate Cancer Risk Genetics Biomarkers Based on Intergraded Bioinformatics Analysis.
    Liang X; Wang Y; Pei L; Tan X; Dong C
    Front Surg; 2022; 9():856446. PubMed ID: 35372462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Potential Key Genes for Pathogenesis and Prognosis in Prostate Cancer by Integrated Analysis of Gene Expression Profiles and the Cancer Genome Atlas.
    Liu S; Wang W; Zhao Y; Liang K; Huang Y
    Front Oncol; 2020; 10():809. PubMed ID: 32547947
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of lncRNA/circRNA-miRNA-mRNA ceRNA Network as Biomarkers for Hepatocellular Carcinoma.
    Chen S; Zhang Y; Ding X; Li W
    Front Genet; 2022; 13():838869. PubMed ID: 35386284
    [No Abstract]   [Full Text] [Related]  

  • 14. Construction of circRNA-Based ceRNA Network to Reveal the Role of circRNAs in the Progression and Prognosis of Hepatocellular Carcinoma.
    Deng R; Cui X; Dong Y; Tang Y; Tao X; Wang S; Wang J; Chen L
    Front Genet; 2021; 12():626764. PubMed ID: 33719338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Prostate Cancer-Related Circular RNA Through Bioinformatics Analysis.
    Wu YP; Lin XD; Chen SH; Ke ZB; Lin F; Chen DN; Xue XY; Wei Y; Zheng QS; Wen YA; Xu N
    Front Genet; 2020; 11():892. PubMed ID: 32922436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-93-5p may be an important oncogene in prostate cancer by bioinformatics analysis.
    Yang Y; Jia B; Zhao X; Wang Y; Ye W
    J Cell Biochem; 2019 Jun; 120(6):10463-10483. PubMed ID: 30582208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a Novel Survival-Related circRNA-miRNA-mRNA Regulatory Network Related to Immune Infiltration in Liver Hepatocellular Carcinoma.
    Gan Y; Fang W; Zeng Y; Wang P; Shan R; Zhang L
    Front Genet; 2022; 13():800537. PubMed ID: 35309118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential biomarkers and pivotal biological pathways for prostate cancer using bioinformatics analysis methods.
    He Z; Duan X; Zeng G
    PeerJ; 2019; 7():e7872. PubMed ID: 31598425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UBASH3B Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Prostate Cancer.
    Wang Z; Wang Y; Peng M; Yi L
    Front Oncol; 2019; 9():1517. PubMed ID: 32010618
    [No Abstract]   [Full Text] [Related]  

  • 20. SNAP25 is a potential prognostic biomarker for prostate cancer.
    Di L; Gu M; Wu Y; Liu G; Zhang L; Li Y; Zhang W
    Cancer Cell Int; 2022 Apr; 22(1):144. PubMed ID: 35392903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.